Rein Therapeutics (RNTX) Earnings Date, Estimates & Call Transcripts $1.94 0.00 (0.00%) As of 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisChartCompetitorsEarningsHeadlinesSEC FilingsTrendsBuy This Stock Rein Therapeutics Earnings Summary Rein Therapeutics released Q1 2025 earnings on May 15, 2025, reporting an EPS of -$0.25, which missed analysts' consensus estimates of -$0.21 by $0.04. With a trailing EPS of -$2.86, Rein Therapeutics' earnings are expected to grow next year, from ($1.56) to ($1.41) per share. Q1 2025 Earnings ResourcesQ1 2025 Earnings ReportConsensus EPS (May. 15) -$0.21 Actual EPS (May. 15) -$0.25 Missed By -$0.04 Get Rein Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Rein Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataRNTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Rein Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.21-$0.21-$0.21Q2 20251-$0.22-$0.22-$0.22Q3 20251-$0.25-$0.25-$0.25Q4 20251-$0.21-$0.21-$0.21 Rein Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails5/15/2025Q1 2025-$0.21-$0.25 -$0.04-$0.25--4/7/2025Q4 2024--$0.26 -$0.26-$1.89-- Rein Therapeutics Earnings - Frequently Asked Questions When did Rein Therapeutics announce their last quarterly earnings? Rein Therapeutics (NASDAQ:RNTX) last announced its quarterly earning data on Thursday, May 15, 2025. Learn more on RNTX's earnings history. Did Rein Therapeutics beat their earnings estimates last quarter? In the previous quarter, Rein Therapeutics (NASDAQ:RNTX) missed the analysts' consensus estimate of ($0.21) by $0.04 with a reported earnings per share (EPS) of ($0.25). Learn more on analysts' earnings estimate vs. RNTX's actual earnings. How much profit does Rein Therapeutics generate each year? Rein Therapeutics (NASDAQ:RNTX) has a recorded net income of -$15.73 million. RNTX has generated -$2.86 earnings per share over the last four quarters. What is Rein Therapeutics's EPS forecast for next year? Rein Therapeutics's earnings are expected to grow from ($1.56) per share to ($1.41) per share in the next year. More Earnings Resources from MarketBeat Related Companies TransCode Therapeutics Earnings CARGO Therapeutics Earnings Cardiff Oncology Earnings ADC Therapeutics Earnings Y-mAbs Therapeutics Earnings Kodiak Sciences Earnings Voyager Therapeutics Earnings Organigram Earnings INmune Bio Earnings DiaMedica Therapeutics Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba's Earnings Just Changed Everything for the StockCisco Stock Eyes New Highs in 2025 on AI, Earnings, UpgradesSymbotic Gets Big Earnings Lift: Is the Stock Investable Again?D-Wave Pushes Back on Short Seller Case With Strong EarningsAppLovin Surges on Earnings: What's Next for This Tech Standout?Can Shopify Stock Make a Comeback After an Earnings Sell-Off?Rocket Lab: Earnings Miss But Neutron Momentum Holds This page (NASDAQ:RNTX) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rein Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rein Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RNTX Stock Free RNTX Stock Alerts